Saxagliptin Inhibits CaMKII Phosphorylation

Medical University of Graz
Stiftingtalstraße 24
Postdoctoral Researcher

Overall

Quality of Results

Ease-of-Optimization

What do these ratings mean?
Write a Review

Company:

Tocris Bioscience

Product Name:

Saxagliptin hydrochloride

Catalog Number:

6507

Saxagliptin is correlated to increased hospitalization for heart failure. We treated cardiomyocytes and followed phosphorylation of CaMKII. Saxagliptin treatment inhibited CaMKII phosphorylation in a concentration dependent manner.

Experimental Design and Results Summary

Application

Cell culture

Starting Material

Cardiomyocytes

Tips

N/A

Results Summary

Saxagliptin reduced pCaMKII expression in cardiomyocytes. This resulted in impaired calcium homeostasis.

DOI or PMID #

N/A

Image Gallery

Summary

The Good

Worked as expected

The Bad

N/A

The Bottom Line

Saxagliptin impairs CaMKII activity and calcium homeostasis in cardiomyocytes.

Join the discussion